# Safety & Efficacy of the J-Valve Ausper System in Patients With Severe Aortic Stenosis and/or Aortic Regurgitation

Study · id `cardio:ct-nct03025971` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03025971](<https://clinicaltrials.gov/study/NCT03025971>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03025971

Browse, organ or system: Heart  
Browse, condition area: Valve and congenital heart disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 107 participants.

## Technical summary

Registry record NCT03025971. Allocation not applicable; no masking; primary purpose treatment. Start 2014-03 (registry gives no type); primary completion 2016-04 (actual). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 107 participants (enrolled count; ClinicalTrials.gov record NCT03025971, source copy `cardio:ctgov-nct03025971-2024-09-19`, retrieved 2026-10-26)
- Start date: 2014-03 (registry gives no type) (ClinicalTrials.gov record NCT03025971, source copy `cardio:ctgov-nct03025971-2024-09-19`, retrieved 2026-10-26)
- Primary completion: 2016-04 (actual) (ClinicalTrials.gov record NCT03025971, source copy `cardio:ctgov-nct03025971-2024-09-19`, retrieved 2026-10-26)
- Completion: 2020-04 (actual) (ClinicalTrials.gov record NCT03025971, source copy `cardio:ctgov-nct03025971-2024-09-19`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT03025971, source copy `cardio:ctgov-nct03025971-2024-09-19`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03025971-2024-09-19`, retrieved 2026-10-26)

## The registry's words

- Brief title: Safety & Efficacy of the J-Valve Ausper System in Patients With Severe Aortic Stenosis and/or Aortic Regurgitation
- Condition: Aortic Valve Disease
- Intervention (Device): J-Valve Transcatheter Aortic valve replacement
- Lead sponsor: JC Medical, Inc., an affiliate of Edwards Lifesciences LLC
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Heart valve disease (`cardio:heart-valve-disease`)

## Provenance

Content hash: a201bcc4e5c962e49f4bfdee5129a840773866933f08f54a2a3118d219f52750
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
